Previous Next


№1' 2022


International Medical Journal, Vol. 28., Iss. 1, 2022, P. 79−83.



Bobrova O. V., Mikhanovska N. G., Kryvonos K. A., Vorobyov S. M.

V. N. Karazin Kharkiv National University, Ukraine

Prevention of COVID−19 and other acute respiratory viral infections is becoming increasingly important. A crucial role in the non−specific prevention of these diseases is played by the awareness of various segments of the population of Ukraine, including schoolchildren, about the observance of hygienic skills as an effective method of preventing the infection spread. In order to determine the level of awareness of children and adolescents of school age about the ways of transmission, features, clinical manifestations and consequences of COVID−19, a study was conducted using the proposed questionnaire developed with the Google Forms application. The research group consisted of 200 students, who were divided into secondary (grades 5−7) and senior (grades 8−11) schools. The percentage of correct answers was determined from the total number of those to each questionnaire. The results of the research showed that high school students showed greater awareness of COVID−19 prevention measures than ones of grades 5−7. Ways to improve awareness among children and adolescents about the principles of prevention of COVID−19 are proposed, namely: questionnaires using Google Forms via the Internet; delivering informative lectures, creating special promotional videos in the form of animated materials on the space of youth platforms (Tik Tok, Instagram); distribution of relevant gif images on social networks; close cooperation between high school students and IT professionals, bloggers who have authority in adolescents, creating outdoor advertising (banners), acquainting students with the "bacterial and viral world" on hand using microscopes in schools. It is advisable to hold special competitions to encourage the audience and raise public awareness (for example, a competition for the best design of a protective mask).

Key words: COVID−19, questionnaire, children and adolescents, preventive measures.


1. This is what Bill Gates had to say about epidemics, back in 2015. URL:−gates−epidemic−pandemic−preparedness−ebola−covid−19

2. British Paediatric Society. Guidance for the clinical management of children admitted to hospital with suspected COVID−19. URL:−03/bprs_management_of_children_admitted_to_hospital_with_covid19_−_20200319.pdf

3. World Health Organization (WHO). COVID−19 Clinical management: living guidance, 25.01.2021. URL:−2019−nCoV−clinical−2021−1

4. World Health Organization (WHO). Tackling antimicrobial resistance in the COVID−19 pandemic. URL:−268573/en/#:~:text=The%20guidance%20does%20not%20recommend,of%20a%20bacterial%20infection%20exist.

5. The Management of Community−Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. URL:

6. Analysis of the Delta Variant B.1.617.2 COVID−19 / Shayan Shiehzadegan, Nazanin Alaghemand, Michael Fox, Vishwanath Venketaraman. Clin. Pract. 2021. Vol. 11 (4). P. 778−784. doi: 10.3390/clinpract11040093PMCID: PMC8544471

7. Recommandations pour le traitement des enfants atteints de COVID−19 Belgian Pediatric Covid−19 Task Force (Adaptation du protocole original de la KULeuven. URL: http://gbs−

8. Fusiono fintelligent learning for COVID−19: Astate−of−the−art review and analysis on real medical data / D. Weiping et al. Neurocomputing. 2021. № 457. R. 40−66

9. Centers for Disease Control and Prevention (CDC). Multisystem Inflammatory Syndrome in Children (MIS−C) Associated with Coronavirus Disease 2019 (COVID−19).

10. American College of Rheumatology. Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS−C) Associated with SARS−CoV−2 and Hyperinflammation in COVID−19. URL:−COVID−19−Clinical−Guidance−Summary−MIS−C−Hyperinflammation.pdf

11. Operativna іnformatsіya pro poshirennya ta profіlaktiku COVID−19. URL:−informacija−pro−poshirennja−koronavirusnoi−infekcii−2019−cov19

12. U. S. Food and Drug Administration (FDA) Expanded Access. URL:−events/public−health−focus/expanded−access

13. URL: Information/VaccineBoosterDoses

14. Genomic−informed pathogen surveillance in Africa: opportunities and challenges / S. C. Inzaule et al. Lancet Infect Dis. 2021. № 21. e281−e289. doi: 10.1016/S1473−3099(20)30939−7

15. Emergence of new SARS−CoV−2 Variant of Concern Omicron (B.1.1.529) − highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID−19 response and control efforts 3 / E. Petersen et al. Int. J. Infect. Dis. 2021. № 114. P. 268−272. doi: 10.1016/j.ijid.2021.11.040

16. Infections Diseases Society of America. IDSA Guidelines on the Treatment and Management of Patients with COVID−19. URL:−guideline/covid−19−guideline−treatment−and−management

17. Nakaz MOZ Ukraїni vіd № 2234 13.10.2021 "Pro vvedennya v dіyu Rіshennya operativnogo shtabu Mіnіsterstva okhoroni zdorov'ya Ukraїni z reaguvannya na situatsії z poshirennya іnfektsіinikh khvorob, yakim mozhna zapobіgti shlyakhom vaktsinatsії vіd 01 zhovtnya 2021 roku". URL:−database/3301−nakaz−moz−ukrayini−vid−13102021−2234

18. National Institute for Health and Care Excellence (NICE). COVID−19 rapid guideline: Managing COVID−19. URL:

19. Yak navchiti uchnіv vіdrіznyati feiki vіd pravdi. URL:

Go on Top